Track the Theriva Biologics, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €10.1m. The latest transaction was disclosed on 8 June 2023 (Acquisition). Among the most active insiders: SHALLCROSS STEVEN A. All data is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€148,488
7 ops.
Buy Volume
n/a
n/a
Sell Volume
34Σ signal
Buys €148,488n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.